Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS PTS
NCT02159521Phase 4Completed
- Sponsor
- Boston Scientific Corporation
- Start
- Jul 2014
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in post-thrombotic syndrome (PTS) and deep vein thrombosis (DVT), sponsored by Boston Scientific Corporation. Primary endpoints: Change From Baseline in Villalta Score at 30 days, Percentage of Segments of Limbs That Achieved at Least 4-Point Reduction From Baseline in Villalta Score at 30 days and 2 more. Started Jul 2014; status: completed.
02
Conditions
post-thrombotic syndrome (PTS)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT02159521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02159521.